Literature DB >> 20937894

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.

Heng Du1, Lan Guo, Shiqiang Yan, Alexander A Sosunov, Guy M McKhann, Shirley ShiDu Yan.   

Abstract

Synaptic dysfunction and the loss of synapses are early pathological features of Alzheimer's disease (AD). Synapses are sites of high energy demand and extensive calcium fluctuations; accordingly, synaptic transmission requires high levels of ATP and constant calcium fluctuation. Thus, synaptic mitochondria are vital for maintenance of synaptic function and transmission through normal mitochondrial energy metabolism, distribution and trafficking, and through synaptic calcium modulation. To date, there has been no extensive analysis of alterations in synaptic mitochondria associated with amyloid pathology in an amyloid β (Aβ)-rich milieu. Here, we identified differences in mitochondrial properties and function of synaptic vs. nonsynaptic mitochondrial populations in the transgenic mouse brain, which overexpresses the human mutant form of amyloid precursor protein and Aβ. Compared with nonsynaptic mitochondria, synaptic mitochondria showed a greater degree of age-dependent accumulation of Aβ and mitochondrial alterations. The synaptic mitochondrial pool of Aβ was detected at an age as young as 4 mo, well before the onset of nonsynaptic mitochondrial and extensive extracellular Aβ accumulation. Aβ-insulted synaptic mitochondria revealed early deficits in mitochondrial function, as shown by increased mitochondrial permeability transition, decline in both respiratory function and activity of cytochrome c oxidase, and increased mitochondrial oxidative stress. Furthermore, a low concentration of Aβ (200 nM) significantly interfered with mitochondrial distribution and trafficking in axons. These results demonstrate that synaptic mitochondria, especially Aβ-rich synaptic mitochondria, are more susceptible to Aβ-induced damage, highlighting the central importance of synaptic mitochondrial dysfunction relevant to the development of synaptic degeneration in AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937894      PMCID: PMC2972922          DOI: 10.1073/pnas.1006586107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  The role of mitochondria in presynaptic calcium handling at a ribbon synapse.

Authors:  D Zenisek; G Matthews
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

2.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

Authors:  I Maurer; S Zierz; H J Möller
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

Review 4.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses.

Authors:  Xiufang Guo; Greg T Macleod; Andrea Wellington; Fangle Hu; Sarvari Panchumarthi; Miriam Schoenfield; Leo Marin; Milton P Charlton; Harold L Atwood; Konrad E Zinsmaier
Journal:  Neuron       Date:  2005-08-04       Impact factor: 17.173

6.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model.

Authors:  Xue Ying He; Guang Yeong Wen; George Merz; Dawei Lin; Ying Zi Yang; Penkaj Mehta; Horst Schulz; Song Yu Yang
Journal:  Brain Res Mol Brain Res       Date:  2002-02-28

8.  beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine.

Authors:  Xavier Mungarro-Menchaca; Patricia Ferrera; Julio Morán; Clorinda Arias
Journal:  J Neurosci Res       Date:  2002-04-01       Impact factor: 4.164

9.  Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.

Authors:  Anna C Schinzel; Osamu Takeuchi; Zhihong Huang; Jill K Fisher; Zhipeng Zhou; Jeffery Rubens; Claudio Hetz; Nika N Danial; Michael A Moskowitz; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

10.  Endophilin I expression is increased in the brains of Alzheimer disease patients.

Authors:  Yimin Ren; Hong Wei Xu; Fleur Davey; Margaret Taylor; Jim Aiton; Peter Coote; Fang Fang; Jun Yao; Doris Chen; John Xi Chen; Shi Du Yan; Frank J Gunn-Moore
Journal:  J Biol Chem       Date:  2007-12-31       Impact factor: 5.157

View more
  295 in total

1.  The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Authors:  A R Esteves; M G-Fernandes; D Santos; C Januário; S M Cardoso
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

3.  Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

Review 4.  Synaptic mitochondrial pathology in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Shirley ShiDu Yan
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

Review 5.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

Review 6.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.

Authors:  Koteswara R Valasani; Gang Hu; Michael O Chaney; Shirley S Yan
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

8.  Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice.

Authors:  Merina Varghese; Wei Zhao; Jun Wang; Alice Cheng; Xianjuan Qian; Amna Chaudhry; Lap Ho; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2011-03-01       Impact factor: 1.757

9.  Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.

Authors:  Yongfu Wang; Long Wu; Jianping Li; Du Fang; Changjia Zhong; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 10.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.